Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical and pharmacokinetic study of PM00104 in Phase II (Zalypsis) in Patients with Advanced Urothelial Carcinoma and / or Metastatic Progress After a First Line Platinum Based Treatment. [Estudio Clínico y Farmacocinético en Fase II de PM00104 (Zalypsis) en Pacientes con Carcinoma Urotelial Avanzado y/o Metastático que Progresa Después de una Primera Línea de Tratamiento Basado en Platino.]

Trial Profile

Clinical and pharmacokinetic study of PM00104 in Phase II (Zalypsis) in Patients with Advanced Urothelial Carcinoma and / or Metastatic Progress After a First Line Platinum Based Treatment. [Estudio Clínico y Farmacocinético en Fase II de PM00104 (Zalypsis) en Pacientes con Carcinoma Urotelial Avanzado y/o Metastático que Progresa Después de una Primera Línea de Tratamiento Basado en Platino.]

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 28 Oct 2015

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs PM 00104 (Primary)
  • Indications Urogenital cancer
  • Focus Therapeutic Use
  • Sponsors PharmaMar
  • Most Recent Events

    • 28 Mar 2012 Status changed from recruiting to completed.
    • 27 Jun 2011 New trial record
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top